Goldman Sachs’s Baird Medical Investment Holdings Warrant BDMDW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.89K Hold
220,004
– – ﹤0.01% 6484
2026
Q1
$17.6K Hold
220,004
– – ﹤0.01% 6363
2025
Q4
$11.2K Hold
220,004
– – ﹤0.01% 6364
2025
Q3
$14.3K Hold
220,004
– – ﹤0.01% 6243
2025
Q2
$17.6K Hold
220,004
– – ﹤0.01% 5989
2025
Q1
$16.5K Hold
220,004
– – ﹤0.01% 5952
2024
Q4
$45.1K Buy
+220,004
New +$8.71K ﹤0.01% 5848

Other funds holding BDMDW

Goldman Sachs's BDMDW Position: Q2 2026 in Review

Goldman Sachs held its Baird Medical Investment Holdings Warrant (BDMDW) position steady in Q2 2026 at 220,004 shares worth $8.89K. The position accounts for ﹤0.01% of the portfolio, ranked #6484.

Goldman Sachs first reported a position in BDMDW in Q4 2024 and has held it in 7 quarters since. The position peaked at $45.1K in Q4 2024. 29 funds tracked by Wall St. Rank hold BDMDW as of Q2 2026.

  • Goldman Sachs held 220,004 shares of Baird Medical Investment Holdings Warrant worth $8.89K as of Q2 2026.
  • Goldman Sachs left its Baird Medical Investment Holdings Warrant share count unchanged in Q2 2026.
  • Baird Medical Investment Holdings Warrant made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #6484 holding.
  • Goldman Sachs first reported a position in Baird Medical Investment Holdings Warrant in Q4 2024 and has held it in 7 quarters since.
  • Goldman Sachs's Baird Medical Investment Holdings Warrant position peaked at $45.1K in Q4 2024.
  • 29 funds tracked by Wall St. Rank held Baird Medical Investment Holdings Warrant as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.